974 related articles for article (PubMed ID: 17276051)
1. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
2. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
[TBL] [Abstract][Full Text] [Related]
5. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
[TBL] [Abstract][Full Text] [Related]
7. Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin Evohaler) in moderate to severe asthmatics.
Lipworth BJ; Sims EJ; Taylor K; Cockburn W; Fishman R
Br J Clin Pharmacol; 2005 Jan; 59(1):5-13. PubMed ID: 15606434
[TBL] [Abstract][Full Text] [Related]
8. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
10. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
11. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.
Salvi S; Brashier B; Gothi D; Karkhanis V; Madas S; Gogtay J; Joshi J
Pulm Pharmacol Ther; 2014 Feb; 27(1):90-5. PubMed ID: 23752057
[TBL] [Abstract][Full Text] [Related]
12. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
[TBL] [Abstract][Full Text] [Related]
14. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of efficacy of salbutamol via metered dose inhaler with volumatic spacer and via dry powder inhaler, easyhaler, to nebulization in mild to moderate severity acute asthma exacerbation in childhood.
Vangveeravong M
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S115-23. PubMed ID: 19253506
[TBL] [Abstract][Full Text] [Related]
16. Comparison of innovator and generic salbutamol inhalers: a double-blind randomized study of efficacy and tolerance.
Pinto Pereira LM; Clement YN; Pinto Pereira SM
Int J Clin Pharmacol Res; 2002; 22(3-4):73-80. PubMed ID: 12837043
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of inhaled beta-agonists v. oral salbutamol in asthma: a randomized double-blind cross-over study.
Thomas K; Peter JV; Cherian AM; Guyatt G
Natl Med J India; 1996; 9(4):159-62. PubMed ID: 8772331
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
19. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
Hordvik NL; Sammut PH; Judy CG; Colombo JL
Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
